Author:
Eshghi Marziye,Yunusova Yana,Connaghan Kathryn P.,Perry Bridget J.,Maffei Marc F.,Berry James D.,Zinman Lorne,Kalra Sanjay,Korngut Lawrence,Genge Angela,Dionne Annie,Green Jordan R.
Abstract
AbstractAlthough speech declines rapidly in some individuals with amyotrophic lateral sclerosis (ALS), longitudinal changes in speech have rarely been characterized. The study objectives were to model the rate of decline in speaking rate and speech intelligibility as a function of disease onset site, sex, and age at onset in 166 individuals with ALS; and estimate time to speech loss from symptom onset. We also examined the association between clinical (speaking rate/intelligibility) measures and patient-reported measures of ALS progression (ALSFRS-R). Speech measures declined faster in the bulbar-onset group than in the spinal-onset group. The rate of decline was not significantly affected by sex and age. Functional speech was still maintained at 60 months since disease onset for most patients with spinal onset. However, the time to speech loss was 23 months based on speaking rate < 120 (w/m) and 32 months based on speech intelligibility < 85% in individuals with ALS-bulbar onset. Speech measures were more responsive to functional decline than were the patient-reported measures. The findings of this study will inform future work directed toward improving speech prognosis in ALS, which is critical for determining the appropriate timing of interventions, providing appropriate counseling for patients, and evaluating functional changes during clinical trials.
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Yorkston, K., Strand, E., Miller, R., Hillel, A. & Smith, K. Speech deterioration in amyotrophic lateral sclerosis: Implications for the timing of intervention. J. Med. Speech. Lang. Pathol. 1, 35–46 (1993).
2. Beukelman, D., Fager, S. & Nordness, A. Communication support for people with ALS. Neurol. Res. Int. 2011, 1–6 (2011).
3. Creer, S., Enderby, P., Judge, S. & John, A. Prevalence of people who could benefit from augmentative and alternative communication (AAC) in the UK: determining the need. Int. J. Lang. Commun. Disord. 51, 639–653 (2016).
4. Brownlee, A. & Bruening, L. M. Methods of communication at end of life for the person with amyotrophic lateral sclerosis. Top. Lang. Disord. 32, 168–185 (2012).
5. Abdulla, S. et al. Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure. J. Neurol. 260, 2242–2255 (2013).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献